Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance

10 May 2021

Abstract excerpt

Prostate cancer (PCa) is the second most commonly occurring cancer in men, with over a million new cases every year worldwide. Tumor growth and disease progression is mainly dependent on the Androgen Receptor (AR), a ligand dependent transcription factor. Standard PCa therapeutic treatments include androgen-deprivation therapy and AR signaling inhibitors. Despite being successful in controlling the disease in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Melanoma and MAPK Pathways
Share to PI3K/AKT/mTOR signaling in cancer
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33972681
DOI: 10.1038/s41388-021-01810-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistancePMID 33972681Read ↗

AR Signaling and the PI3K Pathway in Prostate CancerSemantic proximity Read ↗

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical ApplicationsSemantic proximity Read ↗

Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer.Semantic proximity Read ↗

Castration Resistance in Prostate Cancer Is Mediated by the Kinase NEK6Semantic proximity Read ↗

Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets.Semantic proximity Read ↗

Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challengesSemantic proximity Read ↗

Overexpression of the potential kinase serine/ threonine/tyrosine kinase 1 (STYK 1) in castration‐resistant prostate cancerSemantic proximity Read ↗

Reciprocal regulation between RACGAP1 and AR contributes to endocrine therapy resistance in prostate cancerSemantic proximity Read ↗

Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate CancerSemantic proximity Read ↗

MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP InhibitorsSemantic proximity Read ↗

Ribosomal biogenesis factor, a novel biomarker for predicting progression-free survival in prostate cancerSemantic proximity Read ↗

Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.